Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Direct actions of GLP-1 analogues on AMP-activated protein kinase activity are distinct from cyclic AMP accumulation.

Samson SL, Bajaj M.

J Hepatol. 2013 Mar;58(3):634-5. doi: 10.1016/j.jhep.2012.10.032. Epub 2012 Nov 14. No abstract available.

2.

Reply to: "Direct actions of GLP-1 analogues on AMP-activated protein kinase activity are distinct from cyclic AMP accumulation".

Fishman S, Zvibel I.

J Hepatol. 2013 Mar;58(3):635-6. doi: 10.1016/j.jhep.2012.11.006. Epub 2012 Nov 14. No abstract available.

3.

Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase.

Ben-Shlomo S, Zvibel I, Shnell M, Shlomai A, Chepurko E, Halpern Z, Barzilai N, Oren R, Fishman S.

J Hepatol. 2011 Jun;54(6):1214-23. doi: 10.1016/j.jhep.2010.09.032. Epub 2010 Oct 26.

PMID:
21145820
4.

Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.

Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A.

Liver Int. 2011 Oct;31(9):1285-97. doi: 10.1111/j.1478-3231.2011.02462.x. Epub 2011 Feb 15.

PMID:
21745271
5.

Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.

Burmeister MA, Ferre T, Ayala JE, King EM, Holt RM, Ayala JE.

Am J Physiol Endocrinol Metab. 2012 Feb 1;302(3):E334-43. doi: 10.1152/ajpendo.00409.2011. Epub 2011 Nov 15.

6.

Glucagon-like peptide 1 (GLP-1) can reverse AMP-activated protein kinase (AMPK) and S6 kinase (P70S6K) activities induced by fluctuations in glucose levels in hypothalamic areas involved in feeding behaviour.

Hurtado-Carneiro V, Sanz C, Roncero I, Vazquez P, Blazquez E, Alvarez E.

Mol Neurobiol. 2012 Apr;45(2):348-61. doi: 10.1007/s12035-012-8239-z. Epub 2012 Feb 5.

PMID:
22311299
7.

Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.

Koole C, Wootten D, Simms J, Miller LJ, Christopoulos A, Sexton PM.

J Biol Chem. 2012 Feb 3;287(6):3642-58. doi: 10.1074/jbc.M111.309328. Epub 2011 Dec 6.

8.

Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.

Yusta B, Somwar R, Wang F, Munroe D, Grinstein S, Klip A, Drucker DJ.

J Biol Chem. 1999 Oct 22;274(43):30459-67.

9.

Glucagon-like peptide-1 protects NSC-34 motor neurons against glucosamine through Epac-mediated glucose uptake enhancement.

Lim JG, Lee JJ, Park SH, Park JH, Kim SJ, Cho HC, Baek WK, Kim DK, Song DK.

Neurosci Lett. 2010 Jul 19;479(1):13-7. doi: 10.1016/j.neulet.2010.05.017. Epub 2010 May 13.

PMID:
20471453
10.

Possible involvement of melanocortin-4-receptor and AMP-activated protein kinase in the interaction of glucagon-like peptide-1 and leptin on feeding in rats.

Poleni PE, Akieda-Asai S, Koda S, Sakurai M, Bae CR, Senba K, Cha YS, Furuya M, Date Y.

Biochem Biophys Res Commun. 2012 Mar 30;420(1):36-41. doi: 10.1016/j.bbrc.2012.02.109. Epub 2012 Feb 27.

PMID:
22390932
11.

Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.

Kimball SR, Siegfried BA, Jefferson LS.

J Biol Chem. 2004 Dec 24;279(52):54103-9. Epub 2004 Oct 19.

12.

Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.

Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Silljé HH.

Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1407-14. doi: 10.1161/ATVBAHA.110.206425. Epub 2010 May 6.

13.

Absence of insulinotropic glucagon-like peptide-I(7-37) receptors on isolated rat liver hepatocytes.

Blackmore PF, Mojsov S, Exton JH, Habener JF.

FEBS Lett. 1991 May 20;283(1):7-10.

14.

Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.

Sancho V, Trigo MV, González N, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML.

J Mol Endocrinol. 2005 Aug;35(1):27-38.

15.

Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.

Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX, Xu G, Pu Y, Zhu Z, Xu A, Lam KS, Chen ZY, Ng CF, Yao X, Huang Y.

Hypertension. 2012 Sep;60(3):833-41. doi: 10.1161/HYPERTENSIONAHA.112.195115. Epub 2012 Aug 6.

16.
17.

Glucagon-like peptide-1(7-37) does not stimulate either hepatic glycogenolysis or ketogenesis.

Murayama Y, Kawai K, Suzuki S, Ohashi S, Yamashita K.

Endocrinol Jpn. 1990 Apr;37(2):293-7.

18.

Acute effects of glucagon-like peptide-1 on hypothalamic neuropeptide and AMP activated kinase expression in fasted rats.

Seo S, Ju S, Chung H, Lee D, Park S.

Endocr J. 2008 Oct;55(5):867-74. Epub 2008 May 28.

19.

Protective role of glucagon-like peptide-1 against glucosamine-induced cytotoxicity in pancreatic beta cells.

Kim YK, Park JH, Park SH, Lim B, Baek WK, Suh SI, Lim JG, Ryu GR, Song DK.

Cell Physiol Biochem. 2010;25(2-3):211-20. doi: 10.1159/000276555. Epub 2010 Jan 12.

PMID:
20110682
20.

Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1.

Crajoinas RO, Oricchio FT, Pessoa TD, Pacheco BP, Lessa LM, Malnic G, Girardi AC.

Am J Physiol Renal Physiol. 2011 Aug;301(2):F355-63. doi: 10.1152/ajprenal.00729.2010. Epub 2011 May 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk